Bacterial peptides enhance inflammatory activity in a rat model of colitis

Digestion

Volumn 57, Issue 5, 1996, Pages 368-373

  García Lafuente, Ana ^a   Antolin, María ^a   Guarner, Francisco ^a   Vilascca, Jaime ^a   Malagelada, Juan R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Chemotaxis; Eicosanoids; Inflammatory bowel disease; Leukotrienes; Prostaglandins; Trinitrobenzenesulfonic acid

Indexed keywords

BACTERIAL PROTEIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE B4; MYELOPEROXIDASE; PROSTAGLANDIN E2; THROMBOXANE B2; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DESCENDING COLON; INFLAMMATION; MALE; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COLITIS; DINOPROSTONE; DISEASE MODELS, ANIMAL; EICOSANOIDS; INTESTINAL MUCOSA; LEUKOTRIENE B4; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2; TRINITROBENZENESULFONIC ACID;

EID: 0029740062     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201359     Document Type: Article

References (23)

1. Sartor RB: Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can J Gastroenterol 1990:4:271-277.
2. Chadwick VS, Anderson RP: Microorganisms and their products in inflammatory bowel disease; in McDermott RP. Stenson WF (eds): Inflammatory Bowel Disease. New York. Elsevier, 1992. pp 241-258.
3. Robert A, Asano T; Resistance of germ-free rats to indomcthacin-induced intestinal lesions. Prostaglandins 1977;14:333-341.
4. Kent TH, Cardelli RM, Stamier FW: Small intestinal ulcers and intestinal flora in rats given indomcthacin. Am J Pathol 1969:34:237-245.
5. Bjamason I, Hayllar J, Smethurst P, Price A, Gumjpel MJ: Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug-induced enteropathy. Gut 1992:33:1204-1208.
6. Onderdonk AB, Bartlett JG: Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr 1979:32:258-265.
7. Onderdonk AB, Cisneros RI., Bronson RT: Enhancement of experimental ulcerative colitis by immunization with liacleroides vulgatus. Infect Immun 1983:42:783-788.
8. Onderdonk AB, Sleeves RM, Cisneros RL, Bronson RT: Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect Immun 1984:46:64-67.
9. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG: Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 1978:74:521-526.
10. Okayasu J, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
11. Videla S, Vilaseca J, Guarncr F, Salas A, Tre-serra F, Crespo E, Antolin M, Malagclada JR: Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 1994:35:1090-1097.
12. Chadwick VS, Mellor DM, Myers DB, Seiden AC, Keshavarzian A, Broom MF. Hobson CH: Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol 1988:23:121-1281
13. Painter GR. Sklar LA, Jesaitis AJ, Schmitt M, Cochrane CG: Activation of neutrophils by N-formyl chcmotactic peptides. Fed Proc 1984; 43:2737-2742.
14. Chester JF, Ross JS, Malt RA, Weitzman SA: Acute colitis produced by chcmotactic peptides in rats and mice. Am J Pathol 1985:121:284-290.
15. Zipscr RD, Patterson JB, Leduc LE: Chcmotactic peptide stimulation of lcukotricncs from healthy and inflamed rabbit colons. J Pharmacol Exp Ther 1987:241:218-222.
16. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR: Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of colitis. Gut 1990:31: 539-544.
17. Schierwagen C, Bylund-Fcllenius AC, Lund-bergC: Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990:23:179-186.
18. Rcnlund DG, MacFarlane JL, Christensen RD, Lynch RE. Rothstein G: A quantitative and sensitive method for measurement of myeloperoxidase. Clin Res 1980;28:75A.
19. Rampton DS, Brener NF, Vaja SG, Sladen GF, Dowling RH: Role of prostaglandins in bile salt induced changes in rat colonic structure and function. Clin Sci 1981:61:641-648.
20. Salari H, Braquel P, Naccache P, Borgeat P: Characterization of effect of N-formyl-methio-nyl-phenvlalanine on leukotricnc synthesis in human polymorphonuclear leukocytes. Inflammation 1985:9:127-138.
21. Von Ritter C, Sckizuka E, Grisham MB, Granger DN: The chcmotactic peptide N-formvl mcthionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat. Gastroenterology 1988:95:651-656.
22. Ferry DM, Butt TJ, Broom MF, Hunter J, Chadwick VS: Bacterial chcmotactic oligopeptides and the intestinal mucosal barrier. Gastroenterology 1989:97:61-67.
23. Barrett TA, Musch MW, Chang EB: Chcmotactic peptide effects on intestinal electrolyte transport. Am J Physiol 1990;259:G947-G954.